More difficult still: Treating severe rapidly progressive glomerulonephritis in the context of COVID-19 pneumonia
Nefrologia (Engl Ed). 2021 Jan 28;42(1):94-98.
doi: 10.1016/j.nefro.2020.12.006.
Online ahead of print.
[Article in
English,
Spanish]
Authors
Juan A Martín Navarro
1
, Melissa Cintra Cabrera
2
, Fabio Lucca Proccacini
2
, Jorge Muñoz Rodríguez
3
, David Roldán Cortés
3
, Rafael Lucena Valverde
2
, Mayra Ortega Díaz
2
, Marta Puerta Carretero
2
, Juana Gil Herrera
4
, Maria Teresa Jaldo Rodríguez
2
, Marta Albalate Ramón
2
, Elena Corchete Prats
2
, Laura Medina Zahonero
2
, Patricia de Sequera Ortiz
2
, Roberto Alcázar Arroyo
2
Affiliations
- 1 Servicio de Nefrología, Hospital Universitario Infanta Leonor, Madrid, España. Electronic address: [email protected].
- 2 Servicio de Nefrología, Hospital Universitario Infanta Leonor, Madrid, España.
- 3 Servicio de Anatomía Patológica, Hospital Universitario Infanta Leonor, Madrid, España.
- 4 Servicio de Inmunología, Hospital Gregorio Marañón, Madrid, España.
Abstract
We present the case of a male patient with severe SARS-CoV-2 pneumonia, with simultaneous onset of p-ANCA positive rapidly progressive glomerulonephritis. We discuss the different therapeutic possibilities, emphasising the appropriateness of their administration according to the time in the course of the infection.
Keywords:
ANCA-Associates vasculitis; Aortitis; Glomerulonefritis rápidamente progresiva con semilunas; Infección por SARS-COV2.; Rapidly progressive crescentic glomerulonephritis; SARS-COV2 infection.; Vasculitis asociada a ANCA.
Copyright © 2021 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.